recombinant SARS-CoV-2 S-Trimer vaccine / Wuhan Binhui Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recombinant SARS-CoV-2 S-Trimer vaccine / Wuhan Binhui Biotech
NCT05716347: Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years

Recruiting
1
63
RoW
the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
Binhui Biopharmaceutical Co., Ltd.
COVID-19
12/22
12/23

Download Options